Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariko Kikuchi

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Oral Health|February 28, 2022
Particle Size Analysis in Aerosol-Generating Dental Procedures Using Laser Diffraction TechniqueKaoru Onoyama, Shohei Matsui, Mariko Kikuchi, et al.
Chemotherapy|October 11, 2014
The safety of concentrated trastuzumab in 100 ml of saline solution for administration to patients with HER2-positive breast cancer: a phase 1 studyNorihiko Sengoku, Hirokazu Tanino, Yoshimasa Kosaka, et al.
Biochemical and Biophysical Research Communications|December 25, 2024
Inflammasome regulation by the cell surface ecto-5'-nucleotidase of the oral commensal, Streptococcus oralisNatsuno Nakamura, Hirobumi Morisaki, Momoe Itsumi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[In Situ Ductal Carcinoma with Hereditary Breast and Ovarian Cancer Syndrome in a Patient Who Received Contralateral Risk-Reducing Mastectomy-A Case Report]Yoshimasa Kosaka, Mariko Kikuchi, Hiroshi Nishimiya, et al.
Cancer Science|December 3, 2014
Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancerAkira Ema, Keishi Yamashita, Hideki Ushiku, et al.
International Journal of Oncology|July 6, 2006
Detection of APC gene deletion by double competitive polymerase chain reaction in patients with familial adenomatous polyposisMaho Takahashi, Mariko Kikuchi, Naganari Ohkura, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 10, 2015
Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapyYoshimasa Kosaka, Hirokazu Tanino, Norihiko Sengoku, et al.
Anticancer Research|May 17, 2019
Differential Prognostic Relevance of Promoter DNA Methylation of <i>CDO1</i> and <i>HOPX</i> in Primary Breast CancerYoko Tanaka, Yoshimasa Kosaka, Mina Waraya, et al.
Anticancer Research|January 10, 2014
Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-upHiroshi Nishimiya, Yoshimasa Kosaka, Keishi Yamashita, et al.
Molecular and Clinical Oncology|November 8, 2018
Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancerYoshimasa Kosaka, Naoko Minatani, Yoko Tanaka, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Oral Health|February 28, 2022
Particle Size Analysis in Aerosol-Generating Dental Procedures Using Laser Diffraction TechniqueKaoru Onoyama, Shohei Matsui, Mariko Kikuchi, et al.
Chemotherapy|October 11, 2014
The safety of concentrated trastuzumab in 100 ml of saline solution for administration to patients with HER2-positive breast cancer: a phase 1 studyNorihiko Sengoku, Hirokazu Tanino, Yoshimasa Kosaka, et al.
Biochemical and Biophysical Research Communications|December 25, 2024
Inflammasome regulation by the cell surface ecto-5'-nucleotidase of the oral commensal, Streptococcus oralisNatsuno Nakamura, Hirobumi Morisaki, Momoe Itsumi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2020
[In Situ Ductal Carcinoma with Hereditary Breast and Ovarian Cancer Syndrome in a Patient Who Received Contralateral Risk-Reducing Mastectomy-A Case Report]Yoshimasa Kosaka, Mariko Kikuchi, Hiroshi Nishimiya, et al.
Cancer Science|December 3, 2014
Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancerAkira Ema, Keishi Yamashita, Hideki Ushiku, et al.
International Journal of Oncology|July 6, 2006
Detection of APC gene deletion by double competitive polymerase chain reaction in patients with familial adenomatous polyposisMaho Takahashi, Mariko Kikuchi, Naganari Ohkura, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 10, 2015
Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapyYoshimasa Kosaka, Hirokazu Tanino, Norihiko Sengoku, et al.
Anticancer Research|May 17, 2019
Differential Prognostic Relevance of Promoter DNA Methylation of <i>CDO1</i> and <i>HOPX</i> in Primary Breast CancerYoko Tanaka, Yoshimasa Kosaka, Mina Waraya, et al.
Anticancer Research|January 10, 2014
Prognostic significance of Ki-67 in chemotherapy-naive breast cancer patients with 10-year follow-upHiroshi Nishimiya, Yoshimasa Kosaka, Keishi Yamashita, et al.
Molecular and Clinical Oncology|November 8, 2018
Lymph node metastasis and high serum CEA are important prognostic factors in hormone receptor positive and HER2 negative breast cancerYoshimasa Kosaka, Naoko Minatani, Yoko Tanaka, et al.
Pageof 6